Clinical Trial Update: Cisplatin Plus Romidepsin & Nivolumab in Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC) [Phase 1, Phase 2]

View source ↗

Summary

This document provides an update on a phase 1/2 trial evaluating cisplatin plus romidepsin and nivolumab for locally recurrent or metastatic triple-negative bre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Romidepsin (romidepsin)
• nivolumab (nivolumab)

Snippet

Sponsor: Priyanka Sharma | Conditions: Triple-Negative Breast Cancer, Breast Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING